Adelaide A. Hebert

Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.

S. Forman, L. Stein Gold, S. Guenthner, 2024, Journal of the American Academy of Dermatology.

Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelines

C. Flohr, J. Callen, A. Paller, 2023, Pediatric dermatology.